Monday's Top Wall Street Analyst Research Calls

💡 Dell and Disney among top stocks with new analyst calls this week.

The week has kicked off with a flurry of research calls from top Wall Street analysts, highlighting several stocks that investors may want to keep an eye on. The latest research notes from top analysts suggest that these stocks have significant upside or downside potential, making them worth considering for investors looking to make informed decisions.

Analyst Upgrades

Dell Technologies is one of the top stocks with a new analyst call this week, with UBS upgrading the stock to Buy from Neutral. The analyst cited strong demand for the company's servers and storage solutions. $DVMT is now trading at a price-to-earnings ratio of 12.5, which is lower than its five-year average.

Analyst Downgrades

On the other hand, BioMarin Pharmaceutical is facing a Sell rating from Morgan Stanley, which cited regulatory risks and high valuations. The stock is currently trading at a price-to-earnings ratio of 24.5, which is higher than the S&P 500 average. $BMRN is a key player in the gene therapy space, but the analyst is concerned about the company's pipeline prospects.

Neutral Calls

Disney is another stock that has received a new analyst call this week, with Goldman Sachs maintaining a Neutral rating on the stock. The analyst cited mixed results from the company's latest earnings report, but noted that Disney+ has been a bright spot for the company. $DIS is currently trading at a price-to-earnings ratio of 18.2, which is lower than its five-year average.

What It Means for Investors